TTK Healthcare Ltd.

TTK Healthcare Ltd. has touched a new 52-week low of Rs.949, marking a significant decline in its stock price amid subdued performance metrics and sector headwinds. Despite a modest recovery today, the stock remains under pressure compared to its historical highs and broader market indices.

TTK Healthcare Ltd. has touched a new 52-week low of Rs.954.4 today, marking a significant decline in its share price amid a sustained period of underperformance relative to its sector and benchmark indices.

TTK Healthcare Ltd. has reached a new 52-week low of Rs.954.75, marking a significant decline in its stock price amid broader market fluctuations and company-specific performance trends.

TTK Healthcare Ltd. has reached a new 52-week low of Rs.955.2 on 23 Jan 2026, marking a significant decline amid a sustained downward trend. The stock has underperformed both its sector and broader market indices, reflecting ongoing pressures on its valuation and performance metrics.

TTK Healthcare Ltd., the Chennai-based diversified healthcare company with a market capitalisation of ₹1,532 crores, reported a sharp decline in profitability for Q3 FY26, with net profit falling 48.37% quarter-on-quarter to ₹10.53 crores from ₹20.39 crores in Q2 FY26. The stock, currently trading at ₹988.90, has declined 1.15% following the results announcement, reflecting investor concerns over deteriorating operational efficiency despite modest revenue growth.

TTK Healthcare Ltd. has touched a fresh 52-week low of Rs.965 today, marking a significant decline in its share price amid a sustained downward trend. The stock’s performance continues to lag behind its sector and broader market indices, reflecting ongoing concerns about its financial trajectory and market positioning.

TTK Healthcare Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 July 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 22 January 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

TTK Healthcare Ltd. commenced trading on 22 Jan 2026 with a significant gap up, opening at Rs 1084.2, marking an 8.37% increase from its previous close. This robust start outpaced the broader Sensex, which recorded a modest gain of 0.97% on the same day, signalling a notably positive market response to the stock within the diversified sector.

TTK Healthcare Ltd. demonstrated a robust intraday performance on 22 Jan 2026, surging 8.37% to reach its day high, significantly outperforming the broader Sensex index which gained 0.86% during the session.

TTK Healthcare Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 January 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

TTK Healthcare Ltd. has touched a new 52-week low, closing just 0.8% above its lowest price of Rs 991, reflecting a continuation of its subdued market performance amid broader sector declines and company-specific factors.

TTK Healthcare Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 December 2025, providing investors with an up-to-date perspective on the company’s performance and outlook.

TTK Healthcare Ltd. commenced trading on 30 Dec 2025 with a notable gap up, opening at Rs 1100, marking a 6.49% increase from its previous close. This strong start outpaced the broader Sensex, which marginally declined by 0.06%, signalling a distinct positive sentiment towards the stock within the diversified sector.

TTK Healthcare has reached a 52-week low, with its stock price touching Rs 1023.8 during intraday trading, marking a significant milestone in its recent market trajectory. This development reflects ongoing challenges in the company’s financial performance and market positioning over the past year.

TTK Healthcare’s market evaluation has undergone a revision reflecting a more cautious outlook, influenced by recent financial trends and technical indicators. The stock’s performance over the past year and its standing within the diversified sector have contributed to this reassessment.

TTK Healthcare has reached a new 52-week low, closing just 4.3% above its lowest price of Rs 991, reflecting a continuation of subdued market performance amid broader sector and market trends.